Lipid nanoparticles for mRNA delivery
Messenger RNA (mRNA) has emerged as a new category of therapeutic agent to prevent and treat various diseases. To function in vivo, mRNA requires safe, effective and stable delivery systems that protect the nucleic acid from degradation and that allow ...
Xucheng Hou, Yi-Zhou Dong
exaly +2 more sources
Synergistic effect of nucleoside modification and ionizable lipid composition on translation and immune responses to mRNA vaccines [PDF]
Lipid nanoparticle (LNP) components can impact the safety and immunogenicity of mRNA vaccines. Here we examine the mechanisms contributing to the performance of mRNA-LNP vaccines by exploring the impact of nucleoside modifications and LNP components on ...
Hillary Danz+29 more
doaj +2 more sources
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Over the past several decades, messenger RNA (mRNA) vaccines have progressed from a scepticism-inducing idea to clinical reality. In 2020, the COVID-19 pandemic catalysed the most rapid vaccine development in history, with mRNA vaccines at the forefront ...
Namit Chaudhary, Kathryn A Whitehead
exaly +2 more sources
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic.
Kizzmekia S Corbett+2 more
exaly +2 more sources
Mammalian microRNAs predominantly act to decrease target mRNA levels
MicroRNAs (miRNAs) are endogenous ∼22-nucleotide RNAs that mediate important gene-regulatory events by pairing to the mRNAs of protein-coding genes to direct their repression.
Huili Guo+2 more
exaly +2 more sources
mRNA vaccines — a new era in vaccinology
Norbert Pardi, Michael J Hogan
exaly +2 more sources
Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression
Lori Anne Passmore, Jeff Coller
exaly +2 more sources
Post-transcriptional gene regulation by mRNA modifications
Boxuan Simen Zhao, Chuan He
exaly +2 more sources
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Background As mass vaccination campaigns against coronavirus disease 2019 (Covid-19) commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse populations in a noncontrolled setting.
N. Dagan+9 more
semanticscholar +1 more source
Alterations of mRNA and lncRNA profiles associated with the extracellular matrix and spermatogenesis in goats [PDF]
Objective Spermatozoa are produced within the seminiferous tubules after sexual maturity. The expression levels of mRNAs and lncRNAs in testicular tissues are different at each stage of testicular development and are closely related to formation of the ...
Haolin Chen+7 more
doaj +1 more source